上海睿智化学研究有限公司 CHEMPARTNER
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner 2017-03-24 21:00
ChemPartner Announces its Expansion into Peptide Chemistry 2016-01-07 21:00
ShangPharma and Qidong Biopharma Industrial Zone sign an agreement for a 60 million USD investment in China 2015-09-17 21:15
ChemPartner to showcase cutting edge research at AACR 2015-04-14 05:03
ChemPartner Announces Opening of San Francisco Research Facility 2015-02-03 22:13
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 2014-01-13 22:10
ShangPharma Appoints Pharmaceutical Executive Dr. Arthur Taveras President and CSO 2013-10-28 10:53
ShangPharma Corporation Announces Completion of Merger 2013-03-28 13:41
ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement 2013-03-20 16:23
ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders 2013-02-25 20:00
ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction 2012-12-21 21:47
ShangPharma Announces Third Quarter 2012 Results 2012-11-20 19:00
ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012 2012-11-06 19:00
ShangPharma and Harbour Antibodies Announce Licensing Agreement 2012-09-13 18:00
ShangPharma Announces Second Quarter 2012 Results 2012-08-20 18:00
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012 2012-08-06 18:00
ShangPharma Independent Committee Appoints Financial Advisor 2012-08-03 19:00
ShangPharma Independent Committee Appoints Chairman and Legal Counsel 2012-07-17 20:00
ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS 2012-07-06 19:38
ShangPharma and Lilly Celebrate 10 Years of Partnership 2012-06-04 18:00
1 2 3 4